KIR2DL3/CD158b2 Antibody (014) [FITC]
Novus Biologicals, part of Bio-Techne | Catalog # NBP2-90149F
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA
Label
FITC (Excitation = 495 nm, Emission = 519 nm)
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 014
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for KIR2DL3/CD158b2 Antibody (014) [FITC]
Immunogen
This antibody was obtained from a rabbit immunized with purified, recombinant Human KIR2DL3/CD158b2 (Accession#: AAX23102.1; Met1-His245).
Specificity
Has cross-reactivity in ELISA with: Human KIR2DL4No cross-reactivity in ELISA with: Human KIR2DL1
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Applications for KIR2DL3/CD158b2 Antibody (014) [FITC]
Application
Recommended Usage
ELISA
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
PBS
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: KIR2DL3/CD158b2
Long Name
Killer Cell Immunoglobulin-like Receptor, Two Domain Long Cytoplasmic Tail, 3
Alternate Names
CD158b2, NKAT2
Gene Symbol
KIR2DL3
Additional KIR2DL3/CD158b2 Products
Product Documents for KIR2DL3/CD158b2 Antibody (014) [FITC]
Product Specific Notices for KIR2DL3/CD158b2 Antibody (014) [FITC]
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...